The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice.
SPEAKERS
Elizabeth Sherman, PharmD is associate professor in the department of pharmacy practice at Nova Southeastern University (NSU) in Fort Lauderdale, Florida and HIV/AIDS clinical pharmacy specialist providing clinical service for the Memorial Healthcare System Division of Infectious Disease. She also serves as principal investigator for the NSU local partner site of the Southeast AIDS Education and Training Center in South Florida, part of a network of training centers financed by the Ryan White HIV/AIDS Program.
Dr. Jennifer Cocohoba is Professor of Clinical Pharmacy and Vice Chair for Faculty Development at the University of California, San Francisco School of Pharmacy, Department of Clinical Pharmacy. As a pharmacist for the UCSF Womens HIV Program, she conducts medication consultations and leads quality assurance initiatives around prescribing. Her research interests focus on pharmacy-based interventions to improve adherence, medication use in people living with HIV, and sex differences in antiretroviral pharmacoepidemiology.
Bhavik Shah earned his doctorate of pharmacy from Rutgers University, and completed post-graduate training in pharmacy practice and infectious diseases at Thomas Jefferson University Hospital in Philadelphia, PA. He is an associate professor at the Jefferson College of Pharmacy and co-director of the Pharmacology thread in the JeffMD curriculum at Sidney Kimmel Medical College at Thomas Jefferson University. He is an active member of ASHP and ACCP. Within ASHP, he has served as vice-chair and is currently the chair of the Year-Round Educational Steering Committee for 2020-2021.